Gary A. Lyons is Director at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 20 open-market trades across 2 companies since 2010, most recently 2026-08-18.
CIK 0001123343
5 open-market purchases totalling $32K since 2010, against 15 sales. Across 5 scored buys the stock is up 5.6% at ninety days, and 4.7 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 80% | 80% |
| Avg Move | -12.3% | +8.4% | +5.6% |
| Alpha | -7.4% | +8.4% | +4.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2026-08-17 | 2026-08-19 | $63.28 | $633K | +1.7% | -3.7% | — |
| TVTX | SELL · 10b5-1 | 2026-04-14 | 2026-04-16 | $41.07 | $329K | +1.5% | +6.5% | +40.9% |
| NBIX | SELL · 10b5-1 | 2025-12-03 | 2025-12-04 | $152.61 | $2.3M | -3.7% | -12.0% | -13.6% |
| TVTX | SELL · 10b5-1 | 2024-10-04 | 2024-10-04 | $14.73 | $1.2M | +18.4% | +18.8% | +24.5% |
| NBIX | SELL · 10b5-1 | 2024-08-13 | 2024-08-15 | $150.43 | $3.5M | +3.8% | -16.8% | -14.6% |
| NBIX | SELL · 10b5-1 | 2024-07-16 | 2024-07-18 | $150.03 | $279K | -2.3% | +2.6% | -18.1% |
| NBIX | SELL · 10b5-1 | 2024-05-14 | 2024-05-16 | $135.63 | $1.7M | -5.2% | -4.7% | +3.3% |
| NBIX | SELL · 10b5-1 | 2023-12-22 | 2023-12-27 | $130.04 | $1.3M | +0.8% | +7.2% | +6.4% |
| NBIX | SELL · 10b5-1 | 2023-12-01 | 2023-12-05 | $116.77 | $584K | +1.0% | +12.3% | +11.9% |
| NBIX | SELL · 10b5-1 | 2023-09-12 | 2023-09-14 | $115.02 | $575K | +0.8% | -0.1% | +8.6% |
| NBIX | SELL · 10b5-1 | 2023-09-01 | 2023-09-06 | $110.06 | $550K | +1.2% | +3.0% | +7.1% |
| NBIX | SELL | 2022-10-31 | 2022-11-02 | $114.76 | $1.7M | -3.2% | +4.0% | -9.0% |
| NBIX | SELL | 2022-10-04 | 2022-10-05 | $110.54 | $553K | +2.3% | +12.2% | +10.6% |
| NBIX | SELL | 2022-04-25 | 2022-04-27 | $92.76 | $1.4M | -18.1% | +0.6% | +2.2% |
| NBIX | SELL | 2021-10-07 | 2021-10-12 | $105.06 | $525K | -0.8% | -14.5% | -26.7% |
| NBIX | SELL | 2021-06-10 | 2021-06-14 | $100.27 | $1.0M | +1.3% | -5.5% | -2.6% |
| NBIX | SELL | 2021-01-25 | 2021-01-27 | $120.02 | $240K | +6.2% | -1.2% | -11.8% |
| NBIX | SELL | 2019-11-08 | 2019-11-13 | $110.00 | $550K | +4.4% | +0.4% | -2.9% |
| NBIX | SELL | 2019-11-01 | 2019-11-05 | $100.22 | $501K | +10.7% | +14.0% | -1.7% |
| NBIX | SELL | 2019-07-30 | 2019-07-31 | $92.07 | $1.8M | -2.2% | +2.6% | +1.0% |
| NBIX | SELL | 2018-11-02 | 2018-11-05 | $114.41 | $1.7M | -10.1% | -14.7% | -13.3% |
| NBIX | SELL | 2018-06-13 | 2018-06-15 | $99.24 | $1.5M | -5.0% | +0.1% | +19.4% |
| NBIX | SELL | 2018-02-15 | 2018-02-20 | $84.67 | $423K | +0.6% | -2.0% | +7.2% |
| NBIX | SELL | 2018-02-05 | 2018-02-07 | $83.08 | $415K | +1.8% | +11.2% | -0.1% |
| NBIX | SELL | 2017-12-01 | 2017-12-05 | $72.92 | $729K | +0.2% | +14.1% | +28.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| PARD |
| 206,145 |
| — |
| FACT | 2,500 | — |
| Total | $24.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-19 close. 2 holdings could not be priced and are excluded from the total.